Biosynex (ALBIO) — Working Capital to Net Assets Ratio
Biosynex (ALBIO) has a Working Capital to Net Assets ratio of 81.5% as of June 2025. Working capital of €36.12 Million (current assets of €61.75 Million minus current liabilities of €25.62 Million) is measured against net assets of €44.31 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is Biosynex's balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Biosynex Working Capital to Net Assets (2008–2024)
This chart shows how Biosynex's Working Capital to Net Assets ratio has evolved across 17 annual periods from 2008 to 2024. As of June 2025, the ratio stands at 81.5%, reflecting working capital of €36.12 Million against net assets of €44.31 Million EUR. Check Biosynex (ALBIO) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Biosynex (2008–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Biosynex from 2008 to 2024, covering 17 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Biosynex.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -26.8% | €-21.59 Million | €80.50 Million | €64.39 Million | €85.98 Million | ▼ -67.5 pp |
| 2023 | 40.6% | €50.53 Million | €124.31 Million | €91.35 Million | €40.82 Million | ▼ -31.2 pp |
| 2022 | 71.8% | €119.75 Million | €166.76 Million | €159.24 Million | €39.50 Million | ▼ -15.1 pp |
| 2021 | 86.9% | €145.87 Million | €167.81 Million | €198.78 Million | €52.91 Million | ▲ +24.2 pp |
| 2020 | 62.7% | €41.57 Million | €66.29 Million | €87.53 Million | €45.96 Million | ▲ +40.5 pp |
| 2019 | 22.2% | €6.75 Million | €30.38 Million | €15.11 Million | €8.36 Million | ▼ -2.3 pp |
| 2018 | 24.5% | €7.17 Million | €29.26 Million | €12.41 Million | €5.25 Million | ▼ -3.0 pp |
| 2017 | 27.5% | €7.95 Million | €28.91 Million | €13.71 Million | €5.76 Million | ▲ +10.9 pp |
| 2016 | 16.7% | €4.06 Million | €24.36 Million | €13.37 Million | €9.31 Million | ▲ +6.7 pp |
| 2015 | 10.0% | €2.11 Million | €21.13 Million | €5.73 Million | €3.63 Million | ▼ -43.9 pp |
| 2014 | 53.9% | €1.86 Million | €3.45 Million | €3.58 Million | €1.72 Million | ▲ +0.1 pp |
| 2013 | 53.8% | €2.13 Million | €3.96 Million | €3.84 Million | €1.71 Million | ▼ -3.4 pp |
| 2012 | 57.2% | €2.96 Million | €5.18 Million | €4.50 Million | €1.53 Million | ▼ -35.9 pp |
| 2011 | 93.1% | €4.81 Million | €5.16 Million | €5.17 Million | €365.46K | ▼ -54.6 pp |
| 2010 | 147.8% | €184.09K | €124.59K | €687.61K | €503.52K | ▲ +125.7 pp |
| 2009 | 22.1% | €-75.50K | €-341.55K | €401.40K | €476.90K | ▲ +49.2 pp |
| 2008 | -27.1% | €41.63K | €-153.74K | €396.02K | €354.39K | — |